非酒精性脂肪肝和肥胖之间的相互作用对患心血管疾病的风险的影响
Xue Wang1, Jinlong You1, Jing Tang1
1Institute of Epidemiology and Statistics, School of Public Health, Lanzhou University, Lanzhou, 730000, China.
Scientific reports
|October 14, 2024
概括
非酒精性脂肪肝 (NAFLD) 显著增加了心血管疾病 (CVD) 的风险. 肥胖和NAFLD有协同作用,突出了NAFLD患者体重管理的必要性,以减轻心血管疾病的发展.
科学领域:
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
- 公共卫生 公共卫生
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 越来越多地被认为是一种严重的健康问题.
- 纳FLD与心血管疾病 (CVD) 之间的关联需要进一步调查,以告知预防策略.
研究的目的:
- 探索NAFLD和心血管疾病之间的相关性.
- 在NAFLD的背景下提供关于预防和治疗心血管疾病的证据.
主要方法:
- 利用了金队列平台 (19,399名没有先前存在心血管疾病的参与者) 的数据.
- 采用考克斯模型进行风险分析和相互作用模型 (附加和乘法) 来评估NAFLD和肥胖指标对心血管疾病的综合影响.
主要成果:
- 在调整了混因素后,NAFLD患者患心血管疾病的风险增加了1.17倍.
- 在NAFLD和肥胖指标 (BMI,WC) 之间观察到对心血管疾病风险的积极乘法相互作用.
- 患有肥胖和NAFLD的个体显著增加心血管疾病风险.
结论:
- NAFLD和肥胖是心血管疾病的独立风险因素.
- 纳FLD和肥胖的协同效应强调了对纳FLD患者的体重管理的重要性.
- 较高的BMI和腰围增加了NAFLD患者的心血管疾病风险,特别是女性.
相关概念视频
Obesity
388
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
388
Overview of Lipid Metabolism
1.1K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.1K
Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Diseases of the Liver and Gallbladder
484
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
484
Atherosclerosis II: Clinical manifestations and prevention
2
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
2


